NRx Pharmaceuticals’ Annual Meeting and Spinoff Plans
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, plans to hold its 2023 Annual Meeting of Stockholders on December 19, 2023, in a virtual format. Key items on the agenda include the proposed election of Janet Rehnquist, a respected attorney with extensive experience in regulated industries like healthcare, to the company’s Board of Directors. Additionally, the management […]
Innate Pharma Leadership Change
Innate Pharma, a global clinical-stage biotechnology company, announced a major leadership transition. Mondher Mahjoubi, the Chief Executive Officer (CEO), has resigned to pursue an opportunity at a large pharmaceutical company. Starting January 2024, Hervé Brailly, the current Chairman of the Supervisory Board, former CEO, and co-founder of Innate Pharma, will take over as interim CEO. […]
English 
German